| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Windtree Therapeutics Inc /de/ (WINT) has 0 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. WINT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2021 | Hamill John P. | SVP &CFO | Buy | 1,500 | $3.25 | $4,875.00 | +150.0% | |
| Mar 25, 2021 | Fraser Craig | President And CEO | Buy | 1,500 | $3.25 | $4,875.00 | +6.2% | |
| Oct 28, 2020 | Fraser Craig | President And CEO | Buy | 250 | $6.56 | $1,639.88 | +1.0% | |
| Oct 23, 2020 | Huang James | Director, 10% Owner | Buy | 1,000 | $6.67 | $6,666.00 | +5.0% | |
| Oct 9, 2020 | Fraser Craig | President And CEO | Buy | 250 | $5.83 | $1,456.25 | +1.1% | |
| Oct 8, 2020 | Curtis Eric | SVP &COO | Buy | 500 | $5.27 | $2,635.00 | New | |
| Oct 7, 2020 | Hamill John P. | SVP &CFO | Buy | 1,000 | $5.27 | $5,270.00 | New | |
| Oct 7, 2020 | Fraser Craig | President And CEO | Buy | 250 | $5.17 | $1,292.50 | +1.1% | |
| Jun 4, 2020 | Huang James | Director, 10% Owner | Buy | 12,400 | $7.32 | $90,816.04 | +78.5% | |
| May 22, 2020 | Templeton Mary B Esq | SVP, Gen Counsel &Corp Sec | Buy | 1,103 | $7.25 | $7,996.75 | +3,558% |